Alison Falconer

3.4k total citations
24 papers, 913 citations indexed

About

Alison Falconer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Alison Falconer has authored 24 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Alison Falconer's work include Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Molecular Biology Techniques and Applications (3 papers). Alison Falconer is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Molecular Biology Techniques and Applications (3 papers). Alison Falconer collaborates with scholars based in United Kingdom, Germany and France. Alison Falconer's co-authors include Rosalind A. Eeles, Christopher S. Foster, P Helms, Andrew Dodson, Colin S. Cooper, David J. Stott, Sameer Jhavar, Nening M. Dennis, David Dearnaley and Andrew Feber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Alison Falconer

22 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Falconer United Kingdom 15 396 283 225 158 119 24 913
Wenhua Xiao China 18 500 1.3× 174 0.6× 218 1.0× 231 1.5× 81 0.7× 51 950
Tao Xu China 18 357 0.9× 179 0.6× 250 1.1× 202 1.3× 230 1.9× 104 1.0k
Tao Xu China 19 535 1.4× 252 0.9× 252 1.1× 302 1.9× 237 2.0× 138 1.2k
Ali̇ İnal Türkiye 18 335 0.8× 281 1.0× 290 1.3× 87 0.6× 173 1.5× 95 1.0k
Han Kyeom Kim South Korea 22 349 0.9× 429 1.5× 391 1.7× 142 0.9× 226 1.9× 83 1.3k
Diane M. Biskobing United States 15 386 1.0× 153 0.5× 259 1.2× 60 0.4× 110 0.9× 35 908
Sean P. Martin United States 15 502 1.3× 199 0.7× 392 1.7× 319 2.0× 242 2.0× 33 1.2k
Raffaella Santi Italy 18 201 0.5× 359 1.3× 245 1.1× 194 1.2× 328 2.8× 94 1.3k
R J Davies United Kingdom 17 293 0.7× 245 0.9× 440 2.0× 125 0.8× 275 2.3× 29 1.1k
Giulia Vita Italy 18 296 0.7× 240 0.8× 255 1.1× 150 0.9× 111 0.9× 46 1.2k

Countries citing papers authored by Alison Falconer

Since Specialization
Citations

This map shows the geographic impact of Alison Falconer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Falconer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Falconer more than expected).

Fields of papers citing papers by Alison Falconer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Falconer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Falconer. The network helps show where Alison Falconer may publish in the future.

Co-authorship network of co-authors of Alison Falconer

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Falconer. A scholar is included among the top collaborators of Alison Falconer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Falconer. Alison Falconer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Challapalli, Amarnath, Tara Barwick, Suraiya Dubash, et al.. (2023). Bench to Bedside Development of [18F]Fluoromethyl-(1,2-2H4)choline ([18F]D4-FCH). Molecules. 28(24). 8018–8018. 1 indexed citations
2.
Tanaka, Mariana Bertoncelli, J. H. Burn, Alison Falconer, et al.. (2021). Prostate cancer in transgender women: what does a urologist need to know?. British Journal of Urology. 129(1). 113–122. 42 indexed citations
3.
Connor, Martin J., Mesfin G. Genie, Edward Bass, et al.. (2021). A Systematic Review of Patients’ Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer. European Urology Open Science. 36. 9–18. 11 indexed citations
4.
5.
6.
Pinato, David J., Sarah Howlett, Diego Ottaviani, et al.. (2019). Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice.. Journal of Clinical Oncology. 37(8_suppl). 147–147. 12 indexed citations
7.
Savage, Philip, Rachel Sharkey, Lyn Schofield, et al.. (2013). Malignant spinal cord compression: NICE guidance, improvements and challenges. QJM. 107(4). 277–282. 35 indexed citations
8.
Huddart, Robert, Alison Birtle, Rebecca Lewis, et al.. (2012). Results of the SPARE Feasibility Study – Selective Bladder Preservation Against Radical Excision in Muscle Invasive T2/T3 Transitional Cell Carcinoma of the Bladder (CRUK/07/011). International Journal of Radiation Oncology*Biology*Physics. 84(3). S119–S120. 15 indexed citations
9.
Falconer, Alison, et al.. (2012). Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options. Urology Annals. 4(1). 45–45. 12 indexed citations
10.
Stott, David J., et al.. (2009). Urinary tract infection after stroke. QJM. 102(4). 243–249. 86 indexed citations
11.
Stott, David J., Alison Falconer, Gillian D. Kerr, et al.. (2008). Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People?. Journal of the American Geriatrics Society. 56(12). 2217–2224. 36 indexed citations
12.
Shepherd, Christopher J., Siân Rizzo, Daniel Brewer, et al.. (2008). TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. British Journal of Cancer. 99(11). 1849–1858. 73 indexed citations
13.
Jhavar, Sameer, Carl Fisher, Stefan A. Reinsberg, et al.. (2005). Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. Journal of Clinical Pathology. 58(5). 504–508. 37 indexed citations
14.
Jhavar, Sameer, Catherine M. Corbishley, David Dearnaley, et al.. (2005). Construction of tissue microarrays from prostate needle biopsy specimens. British Journal of Cancer. 93(4). 478–482. 27 indexed citations
15.
Lee, Yin-Fai, Alison Falconer, S M Edwards, et al.. (2004). A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas. Cancer Research. 64(20). 7201–7204. 59 indexed citations
16.
Angèle, Sandra, Alison Falconer, Christopher S. Foster, et al.. (2004). ATM Protein Overexpression in Prostate Tumors Possible Role in Telomere Maintenance. American Journal of Clinical Pathology. 121(2). 231–236. 24 indexed citations
17.
Foster, Christopher S., Alison Falconer, Andrew Dodson, et al.. (2004). Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene. 23(35). 5871–5879. 134 indexed citations
18.
Angèle, Sandra, Alison Falconer, S M Edwards, et al.. (2004). ATM polymorphisms as risk factors for prostate cancer development. British Journal of Cancer. 91(4). 783–787. 75 indexed citations
19.
Feber, Andrew, Jeremy Clark, Graham H. Goodwin, et al.. (2003). Amplification and overexpression of E2F3 in human bladder cancer. Oncogene. 23(8). 1627–1630. 132 indexed citations
20.
Falconer, Alison, et al.. (1993). Poor agreement between reported and recorded nocturnal cough in asthma. Pediatric Pulmonology. 15(4). 209–211. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenhua Xiao Breakdown of academic impact, for papers by Tao Xu Breakdown of academic impact, for papers by Tao Xu Breakdown of academic impact, for papers by Ali̇ İnal Breakdown of academic impact, for papers by Han Kyeom Kim Breakdown of academic impact, for papers by Diane M. Biskobing Breakdown of academic impact, for papers by Sean P. Martin Breakdown of academic impact, for papers by Raffaella Santi Breakdown of academic impact, for papers by R J Davies Breakdown of academic impact, for papers by Giulia Vita
Rankless by CCL
2026